Poor Hematopoietic Stem Cell Mobilizers in Multiple Myeloma: a Single Institution Experience
2010

Poor Stem Cell Mobilization in Multiple Myeloma

Sample size: 28 publication Evidence: moderate

Author Information

Author(s): Guillermo J. Ruiz-Delgado, Avril López-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo J. Ruiz-Argüelles

Primary Institution: Centro de Hematología y Medicina Interna de Puebla

Hypothesis

What is the prevalence of poor mobilization in individuals with multiple myeloma undergoing autologous stem cell transplantation?

Conclusion

Patients with multiple myeloma who are poor mobilizers have worse long-term overall survival compared to those with adequate mobilization.

Supporting Evidence

  • 26 patients received autografts after stem cell mobilization attempts.
  • 8 patients were identified as poor mobilizers.
  • Patients grafted with more than 1 x 106 CD34+ cells had an 80% survival rate at 80 months.

Takeaway

Some patients with multiple myeloma have trouble collecting enough stem cells for treatment, which can make their recovery harder.

Methodology

The study analyzed 28 myeloma patients who underwent stem cell mobilization and autografting, assessing the number of CD34+ cells collected.

Potential Biases

Potential biases may arise from the single-institution study design and the specific patient population.

Limitations

The study had a small sample size, which may limit the generalizability of the findings.

Participant Demographics

The median age of participants was 54 years, with 13 females and 15 males.

Digital Object Identifier (DOI)

10.4084/MJHID.2010.016

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication